Founder and Chairman of Black Beret Life Sciences, LLC is lauded for his leadership role in advancing regenerative medicine
Miami, FL (Jan. 24, 2018) – Dr. W. E. “Ed” Bosarge, the Founder and Chairman of Black Beret Life Sciences LLC, was presented with this year’s Leadership Award at a gala reception and dinner during the 13th annual World Stem Cell Summit (WSCS) at the Hyatt Regency Miami in Miami, Florida. Dr. Bosarge was honored by the Regenerative Medicine Foundation (RMF) at its annual Stem Cell and Regenerative Medicine Action Awards for his efforts in advancing the emerging field of regenerative medicine and game-changing cell therapy medical treatments.
In presenting the prestigious award, Bernard Siegel, founder of the WSCS and the Executive Director of RMF, described Dr. Bosarge as a bridge builder as well as a man of action and vision. “We are grateful for the opportunity to honor one of the true pioneers and visionaries of regenerative medicine. Dr. Bosarge is a hero. His strategic vision is leading us toward cures and treatments that will alleviate human suffering. It is fitting that he is being celebrated at WSCS, among the researchers, scientists and advocates who know the true impact of his work.”
“I am challenging my team and all of us here to practice science and medicine of the highest quality as we all work for regenerative medicine to come of age,” said Dr. Bosarge. “To do it with transparency, interdisciplinary teams who collaborate, and excellence.”
Dr. Bosarge paid special recognition to the executive team at BBLS, led by Dr. Marc Penn who has helped focus efforts in research, in treating patients and in recruiting world-class talent. He also acknowledged Dr. Vincent Burton, President of the Okyanos Center for Regenerative Medicine in Freeport, Bahamas, as well as the team of doctors and nurses there. Okyanos is part of the BBLS portfolio of companies, bringing novel stem cell treatments to patients with chronic conditions and diseases.
“So many at BBLS are doing what you here are doing,” he told the audience. “Top quality tireless science, research and therapeutics, working to crack the code and move regenerative medicine forward.”
Dr. Bosarge joined four other honorees selected for the Regenerative Medicine Foundation (RMF) 2018 Stem Cell and Regenerative Medicine Action Awards. They included former U.S. Vice President Joe Biden and Dr. Jill Biden (Advocacy Award) Shelly Ross and the Cure Alliance (Advocacy Award), Sickle Cell and stem cell advocate Adrienne Bel-Cors Shapiro (Inspiration Award) and Professor Norio Nakatsuji, the Founding Director of the Institute for Integrated Cell-Material Sciences (iCeMS) at Kyoto University in Japan (International Leadership Award). Each year, RMF celebrates the stem cell and regenerative medicine community’s top innovators, leaders, and champions.
About Dr. Ed Bosarge
Dr. W. E. “Ed” Bosarge is an acknowledged world leader in the emerging field of regenerative medicine. His passionate commitment to advancing biotechnology innovations has resulted in game-changing treatments for orthopedic conditions, cardiovascular diseases, neurological disorders, cancer, diabetes and other chronic conditions. As Chairman and Founder of Black Beret Life Sciences, Dr. Bosarge maintains an international focus on accelerating the development and clinical introduction of cutting edge regenerative medical, adult stem cell and immunotherapy treatments. In an effort to bring scientific discovery and medical innovation back to the forefront of clinical practice in the US, Dr. Bosarge recently spearheaded a federal legislative initiative supporting the FDA’s leadership to advance approval of safe and effective cell-based therapies which would allow Americans with debilitating or life-threatening diseases expedited access to new potentially life-changing or life-saving treatments.
About Black Beret Life Sciences
Black Beret Life Sciences (BBLS) is the investment and management arm of the Houston-based Bosarge Family Office. The firm was established in 2014 by Dr. Ed Bosarge to organize and manage investments in potentially game-changing bio-technology and healthcare companies focused on regenerative medicine, anti-aging and immunotherapy. With an overall goal of extending healthier life, BBLS’ portfolio of managed investments includes companies and research across an array of disease spectrums, including diabetes, neurodegeneration, osteoarthritis, cancer immunotherapy and various conditions related to aging. BBLS is based in Houston, Texas, with offices worldwide. Learn more at https://www.bbls.net.